ClearPoint Neuro, Inc. (CLPT) › Cash & EquivalentsClearPoint Neuro, Inc. (CLPT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $2.57M2010: $1.58M2011: $145.5K2012: $1.62M2013: $3.52M2014: $9.24M2015: $5.41M2016: $3.32M2017: $9.29M2018: $3.10M2019: $5.70M2020: $20.10M2021: $54.11M2022: $27.61M2023: $23.14M2024: $20.10M2025: $45.92M$45.92M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$45.92M+128.4%2024$20.10M-13.1%2023$23.14M-16.2%2022$27.61M-49.0%2021$54.11M+169.2%2020$20.10M+252.9%2019$5.70M+83.7%2018$3.10M-66.6%2017$9.29M+180.2%2016$3.32M-38.7%2015$5.41M-41.5%2014$9.24M+162.9%2013$3.52M+117.1%2012$1.62M+1013.6%2011$145.5K-90.8%2010$1.58M-38.6%2009$2.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share